Literature DB >> 9619900

The risk of treatment. A study of rheumatoid arthritis patients' attitudes.

M Ho1, B Lavery, T Pullar.   

Abstract

Despite its importance, there is no well-validated method of measuring patients' concept of 'acceptable' risk of medical treatment. Numerical methods give widely varying results depending on the methodology. We have attempted to assess 'acceptable' risk using relative comparisons. We administered a questionnaire to 67 patients with rheumatoid arthritis (RA). In general, patients' estimate of acceptable risk was less than the actual risk of treatment. Some illogical choices were made, showing poor understanding by patients of the concepts of risk and risk:benefit ratio. Patients appeared willing to accept higher levels of risk from procedures than from drug treatment. Willingness to accept risk in exchange for successful treatment of their RA did not correlate with disease severity, age, willingness to take non-medical risks or family responsibilities.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9619900     DOI: 10.1093/rheumatology/37.4.459

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  7 in total

1.  Measuring pain impact versus pain severity using a numeric rating scale.

Authors:  Liana Fraenkel; Paul Falzer; Terri Fried; Minna Kohler; Ellen Peters; Robert Kerns; Howard Leventhal
Journal:  J Gen Intern Med       Date:  2011-11-12       Impact factor: 5.128

Review 2.  Medication adherence in patients with rheumatoid arthritis: why do patients not take what we prescribe?

Authors:  Peter K K Wong
Journal:  Rheumatol Int       Date:  2016-09-24       Impact factor: 2.631

Review 3.  Tumour necrosis factor-alpha antagonists in the management of rheumatoid arthritis in the elderly: a review of their efficacy and safety.

Authors:  Beáta J Radovits; Wietske Kievit; Roland F J M Laan
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

4.  Patient preferences for treatment of rheumatoid arthritis.

Authors:  L Fraenkel; S T Bogardus; J Concato; D T Felson; D R Wittink
Journal:  Ann Rheum Dis       Date:  2004-03-05       Impact factor: 19.103

5.  Treating rheumatoid arthritis to target: the patient version of the international recommendations.

Authors:  M P T de Wit; J S Smolen; L Gossec; D M F M van der Heijde
Journal:  Ann Rheum Dis       Date:  2011-04-07       Impact factor: 19.103

Review 6.  Medication adherence in patients with rheumatoid arthritis: the effect of patient education, health literacy, and musculoskeletal ultrasound.

Authors:  Samantha Joplin; Rick van der Zwan; Fredrick Joshua; Peter K K Wong
Journal:  Biomed Res Int       Date:  2015-04-28       Impact factor: 3.411

7.  Preferences of patients and health professionals for route and frequency of administration of biologic agents in the treatment of rheumatoid arthritis.

Authors:  Tuan Khai Huynh; Ann Ostergaard; Charlotte Egsmose; Ole Rintek Madsen
Journal:  Patient Prefer Adherence       Date:  2014-01-20       Impact factor: 2.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.